Barron'sSarepta Therapeutics' Duchenne Muscular Dystrophy Gene Therapy Gets FDA ApprovalJun 22, 2023more_vert
Investor Relations | Sarepta Therapeutics, Inc.Sarepta Therapeutics Announces FDA Approval of ELEVIDYS, the First Gene Therapy to Treat Duchenne Muscular ...Jun 22, 2023more_vert
Science News MagazineThe first gene therapy for muscular dystrophy has been approved for some kidsJun 22, 2023Tina Hesman SaeyBy Tina Hesman Saeymore_vert
ReutersUS FDA approves Sarepta's gene therapy for rare muscular dystrophy in some kidsJun 22, 2023Aditya Samal & Leroy LeoBy Aditya Samal & Leroy Leomore_vert
The Associated PressFirst gene therapy for deadly form of muscular dystrophy gets FDA approval for young kidsJun 22, 2023Matthew PerroneBy Matthew Perronemore_vert
NPRIn a first, FDA approves Sarepta gene therapy for Duchenne muscular dystrophy : Shots - Health NewsJun 22, 2023Rob SteinBy Rob Steinmore_vert